JPS61112073A - Production of 1-(2-tetrahydrofuryl)-5-fluorouracil - Google Patents

Production of 1-(2-tetrahydrofuryl)-5-fluorouracil

Info

Publication number
JPS61112073A
JPS61112073A JP59232498A JP23249884A JPS61112073A JP S61112073 A JPS61112073 A JP S61112073A JP 59232498 A JP59232498 A JP 59232498A JP 23249884 A JP23249884 A JP 23249884A JP S61112073 A JPS61112073 A JP S61112073A
Authority
JP
Japan
Prior art keywords
carboxylic acid
fluorouracil
reaction
tetrahydrofuryl
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59232498A
Other languages
Japanese (ja)
Other versions
JPH0430956B2 (en
Inventor
Teruo Umemoto
照雄 梅本
Eiji Ogura
小倉 英二
Takamoto Mukono
向野 孝元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onoda Cement Co Ltd
Sagami Chemical Research Institute
Original Assignee
Onoda Cement Co Ltd
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onoda Cement Co Ltd, Sagami Chemical Research Institute filed Critical Onoda Cement Co Ltd
Priority to JP59232498A priority Critical patent/JPS61112073A/en
Priority to KR1019850008257A priority patent/KR920006418B1/en
Priority to CN85108855A priority patent/CN1014893B/en
Publication of JPS61112073A publication Critical patent/JPS61112073A/en
Publication of JPH0430956B2 publication Critical patent/JPH0430956B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain the titled compound economically and easily, in high yield and purity, by reacting 5-fluorouracil with 2,3-dihydrofuran in pyridine in the presence of a carboxylic acid, and treating the obtained reaction liquid with an aqueous solution of a carboxylic acid salt. CONSTITUTION:The objective compound of formula III can be prepared by reacting 5-fluorouracil of formula I with 2,3-dihydrofuran of formula II in the presence of a carboxylic acid such as lower aliphatic carboxylic acid at 80-180 deg.C, adding an aqueous solution of a carboxylic acid salt such as an alkali metal or alkaline earth metal salt of a <=8C carboxylic acid to the reaction solution, and treating at a temperature between room temperature and 100 deg.C. The amount of the carboxylic acid is 0.1-2.5mol per 1mol of the compound of formula I, and the concentration of the aqueous solution of carobxylic acid salt is 0.01-10mol. EFFECT:The carboxylic acid salt acts also as a salting-out agent in the extraction of the reaction product to improve the extraction efficiency. USE:Antitumor agent, antiviral agent, etc.

Description

【発明の詳細な説明】 〔発明の目的〕 本発縫澁鷺純度の1−(2−ナト2ヒト・フリル)−5
−フルオロウラシルを工業的に安価にしかも簡便に製造
するための方法に関するものであみ。
[Detailed Description of the Invention] [Object of the Invention] 1-(2-Nato2 Human Frill)-5 of Honhatsu Shibusagi Purity
-Related to a method for manufacturing fluorouracil industrially at low cost and simply.

〔産業上の利用分野〕[Industrial application field]

1−(2−テトラヒドロフリル)−5−フルオロウラシ
ルは抗腫瘍剤、抗ビールス剤などとして、公知の化合物
である。
1-(2-tetrahydrofuryl)-5-fluorouracil is a compound known as an antitumor agent, an antiviral agent, and the like.

〔従来の技術〕[Conventional technology]

従来、1−(2−テトラヒドロフリル)−5−フルオロ
ウラシルの製造方法としては種々の方法が知られている
が、工業的に安価で簡便に製造するにはいくつかの問題
点がある。1−(2−テトラヒドロフリル)−5−フル
オロウラシルの化学構造は、基本的に5−フルオロウラ
シルの部分とテトラヒドロフリルの部分とから成ってお
り、工業的にこれらの二つの部分をいかに結合させるか
多くの研究がな式れている。
Conventionally, various methods have been known for producing 1-(2-tetrahydrofuryl)-5-fluorouracil, but there are several problems in producing it industrially at low cost and simply. The chemical structure of 1-(2-tetrahydrofuryl)-5-fluorouracil basically consists of a 5-fluorouracil moiety and a tetrahydrofuryl moiety, and there are many problems in how to combine these two moieties industrially. A lot of research has been done.

従来法では、5−フルオロウラシル部分の反応基質とし
て5−フルオロウラシル水銀塩(英国特許、44116
8391号参照)、2,4−ビス(トリアルキルシリル
)−5−フルオロウラシル(タ、!:、tば特開昭53
−135989参照)、又は、2,4−ビス(トリアル
キルスタニル)−5−フルオロウラシル(たとえば特開
昭53−137973参照)を用いる方法が知られてい
るが、これらはいずれも5−フルオロウラシルから凡戦
的高価な試剤を匣って2課遺しなければならないため経
済性及び工程数の増加から工業的には好ましくない。ま
た特に5−フルオロウラシル水銀塩を用いる方法は水銀
の人体に対する毒性、環境汚染の問題がろる。健って工
業的に有利と考えられる製造方法としては入手容易な5
−フルオロウラシルそのものを使用して、テトラヒドロ
フリル部分の反応基質と反応させる方法でろる。
In the conventional method, 5-fluorouracil mercury salt (British patent, 44116
8391), 2,4-bis(trialkylsilyl)-5-fluorouracil (T,!:, t), JP-A-1983
-135989) or 2,4-bis(trialkylstannyl)-5-fluorouracil (for example, see JP-A-53-137973), but both of these methods are made from 5-fluorouracil. This method is unfavorable from an industrial perspective because of the cost and increase in the number of steps, since it requires storing expensive reagents in two containers. In particular, the method using 5-fluorouracil mercury salt has problems of mercury toxicity to the human body and environmental pollution. The manufacturing method that is considered to be industrially advantageous is 5, which is easily available.
- Fluorouracil itself is used to react with the reaction substrate of the tetrahydrofuryl moiety.

テトラヒドロフリル部分の反応基質としては、たとえば
、2−クロロテトラヒドロフラン(たとえは英国特許第
1168391号、特公昭49−105101特開昭5
1−8282、特公昭53−            
[1)518参照)、2−アルコキシテトラヒドロ7ラ
ン(たとえば特開昭49−1)7981 、特開昭52
−118479参照)、2−アシロキシテトラヒドロフ
クン(たとえば特開昭5℃〜50383、特開昭53−
7688参照)を用いる方法が知られているが、これら
の化合物の化学的安定性は低く、特に2−クロロテトラ
ヒドロフランはきわめて不安定な化合物であるため、−
60℃〜−10゛C位の低温で反応を行わなければなら
ないためその取り扱い等を含め工業的に不利でおる。ま
た2−アルコキシテトラヒドロフランおよび2−アゾロ
キノテトラヒドロフクンは、通常2−クロロテトラヒド
ロ7ラン又は2.3−ジヒドロフランから製造され、又
、2−クロロテトラヒドロフランは2.3−ジヒドロフ
ランから製造される化合物でめるので前記の方法は反応
工程数が多く工業的に有利な方法とは言えない。
As the reaction substrate of the tetrahydrofuryl moiety, for example, 2-chlorotetrahydrofuran (for example, British Patent No. 1168391, Japanese Patent Publication No. 105101/1986,
1-8282, Tokuko Sho 53-
[1) 518), 2-alkoxytetrahydro7rane (for example, JP-A-49-1) 7981, JP-A-52
-118479), 2-acyloxytetrahydrofucn (e.g., JP-A-5C-50383, JP-A-53-
7688), but the chemical stability of these compounds is low, and in particular 2-chlorotetrahydrofuran is an extremely unstable compound, so -
Since the reaction must be carried out at a low temperature of about 60 DEG C. to -10 DEG C., it is industrially disadvantageous, including its handling. In addition, 2-alkoxytetrahydrofuran and 2-azoloquinotetrahydrofuran are usually produced from 2-chlorotetrahydro7rane or 2,3-dihydrofuran, and 2-chlorotetrahydrofuran is produced from 2,3-dihydrofuran. Since the method involves a large number of reaction steps, it cannot be said to be an industrially advantageous method.

また5−フルオロウラシル部分と反応させるテトラヒド
ロフリル部分の反応基質として、塩化スルフリル存在下
、テトラヒドロ7ランを用いる方法が知られているが(
特開昭53−119881参照)、この方法は1−(2
−テトラヒドロフリル)−5−フルオロウラシルの収ご
旨が低い上、毒性の強い塩化スルフリルを使用すること
、又、反応中腐食性の強い塩化水素が発生するため工業
的には採用しがたい。
Furthermore, a method is known in which tetrahydro7rane is used in the presence of sulfuryl chloride as a reaction substrate for the tetrahydrofuryl moiety to be reacted with the 5-fluorouracil moiety (
(Refer to Japanese Unexamined Patent Publication No. 53-119881.
-tetrahydrofuryl)-5-fluorouracil, the highly toxic sulfuryl chloride is used, and highly corrosive hydrogen chloride is generated during the reaction, so it is difficult to adopt it industrially.

従って以上の数々の問題点から見て、工高的に有利と考
えられる原料は、5−フルオロウラシル部分とテトラヒ
ドロフリル部分は、それぞれ入手容易でしかも化学的安
定な5−フルオロウラノルと2,3−ジヒドロフランで
ろると6える。更に5−フルオロウラシルと2.3−ジ
ヒドロフランとの反応は完全な2分子結合反応(下記反
応弐零照)と予想されるため、反応後の精製工僅で分離
操作が簡便になるという有利点がろる。これらの理由か
ら両者を原料として採用したいくつかの方法が報告され
ている。たとえば極性溶媒中加熱する方法(特開昭53
−119880及び特公昭53−28435参照)、加
圧条件下加熱する方法(特公昭54−1)472参照)
が知られているが、いずれも反応に高温及び長時間を要
すること、また反応の効率が低く、副生成物の1.3−
ビス(2−テトラヒドロフリル)−5−フルオロウラク
ルが生成し、後処理での精製工程が複雑になるという欠
点があった。それらの欠点を補なう目的で反応促進剤と
して、たとえば+11無水塩化アルミニウム等のルイス
酸(特開昭53−2484.52−89678参照)、
(2)五塩化燐(特開昭54−27583参照)、(3
)クロロホスファイト(特開昭54−301’87参照
) 、 (4)第3級アミン塩酸塩(特開昭54−27
584参照)、(5)アミノ酸等の両性化合物(特公昭
54−9179参照)、又fi(6)強酸性力チオ/交
換樹脂、強塩基性アニオン交換樹脂等(特公昭53−3
5954参照)の共存下反応させる方法が報告されてい
るが、これらの方法は、通常の条件下では留去すること
のできない固形の化合物を添加するため後処理の精製工
程における複雑さはまぬがれない。また特に前記(11
〜(3)の反応条件下では反応中又は後処理工程で多量
の塩化水素が発生するため腐食の問題が生じる。また(
4)の場合も塩7g塩を用いているため腐食の問題はま
ぬがれない。さらにこれらの方法においても副生成物で
める1、3−ビス(2−テトラヒドロフリル)−5−フ
ルオロウラシルの生成は避は得られないため、精製工程
及び収率の点で問題を残している。当該欠点を解決する
ものとして副生じた1、3−ビス(2−テトラヒドロフ
リル)−5−フルオロウラクルを酸性又はアルカリ性加
水分解して目的物でろる1−(2−テトラヒドロフリル
)−5−フルオロウラクルに変at         
   ’る方法(特開昭53−119880、特公昭5
6−10911参照)が提案されているが、目的物の1
−(2−テトラヒドロフリル) −5−フルオロウラシ
ルも同様に酸又はアルカリ加水分解されて原料の5−フ
ルオロウラシルに変換されるため、その副反応を生起さ
せずに、1.3−ビス(2−テトラヒドロフリル)−5
−フルオロウラクルのみを選択的に加水分解するための
反応条件の4囲は非常に狭い。このため工業的に実施し
ようとする場合問題点が多い。また従来加水分解を行な
うにz”l fV は、前段階棲反応後ρ媒留去等の操作が必要なため、工
業的に簡便な製造方法とは言いがたい。
Therefore, in view of the above-mentioned problems, the raw materials considered to be advantageous in terms of manufacturing cost are 5-fluorouracil moiety and tetrahydrofuryl moiety, which are easily available and chemically stable, and 5-fluorouranol and 2,3 - Dihydrofuran makes Roto 6. Furthermore, since the reaction between 5-fluorouracil and 2,3-dihydrofuran is expected to be a complete two-molecular bonding reaction (reaction number 2 shown below), it has the advantage that it requires only a few purification steps after the reaction and the separation operation is simple. Roru. For these reasons, several methods using both as raw materials have been reported. For example, a method of heating in a polar solvent (Japanese Unexamined Patent Publication No. 53)
-119880 and Japanese Patent Publication No. 53-28435), method of heating under pressurized conditions (see Japanese Patent Publication No. 54-1) 472)
However, in both cases, the reaction requires high temperature and long time, the reaction efficiency is low, and the by-product 1.3-
There was a drawback that bis(2-tetrahydrofuryl)-5-fluorouracul was produced, complicating the purification process in post-treatment. In order to compensate for these drawbacks, Lewis acids such as +11 anhydrous aluminum chloride (see JP-A-53-2484.52-89678),
(2) Phosphorus pentachloride (see JP-A-54-27583), (3
) chlorophosphite (see JP-A-54-301'87), (4) tertiary amine hydrochloride (JP-A-54-27)
584), (5) Amphoteric compounds such as amino acids (see Japanese Patent Publication No. 54-9179), and fi (6) strongly acidic thio/exchange resins, strong basic anion exchange resins, etc. (Japanese Patent Publication No. 53-3)
5954) have been reported, but these methods inevitably add complexity to the post-treatment purification process because they add solid compounds that cannot be distilled off under normal conditions. . In particular, the above (11
Under the reaction conditions of (3), a large amount of hydrogen chloride is generated during the reaction or in the post-treatment process, resulting in the problem of corrosion. Also(
In the case of 4), since 7g of salt is used, the problem of corrosion cannot be avoided. Furthermore, even in these methods, the production of 1,3-bis(2-tetrahydrofuryl)-5-fluorouracil as a by-product cannot be avoided, so problems remain in terms of the purification process and yield. . To solve this problem, 1-(2-tetrahydrofuryl)-5-, which is produced by acidic or alkaline hydrolysis of the by-produced 1,3-bis(2-tetrahydrofuryl)-5-fluorouracul, yields the desired product. Changed to fluorouracula
method (Japanese Unexamined Patent Publication No. 53-119880,
6-10911) has been proposed, but if one of the objects
-(2-tetrahydrofuryl) -5-fluorouracil is similarly hydrolyzed with acid or alkali and converted to the raw material 5-fluorouracil, so 1,3-bis(2-tetrahydrofuryl) is converted into the raw material 5-fluorouracil without causing side reactions. frill)-5
- The range of reaction conditions for selectively hydrolyzing only fluorouracules is very narrow. For this reason, there are many problems when trying to implement it industrially. In addition, in conventional hydrolysis, z"l fV requires operations such as distillation of the ρ medium after the preliminary reaction, and therefore cannot be called an industrially simple production method.

〔発明が解決した問題点〕[Problems solved by the invention]

本発明者らは以上の数々の問題点を勘案し、工業的に簡
便にしてかつ安価な製造方法を見い出すべく、鋭意研究
を重ねた結果、5−フルオロウラクルと2,3−ジヒド
ロフクンとの反応は、ピリジン溶媒中、カルボン酸を共
存させることにより、それを存在させない場合に比べ反
応効率が増大すること(比較例参照)、さらには得られ
た反応ぴ媒を溶媒留去することなしにそのままカルボン
酢塩の水溶液を加えて処理することにより主成した1−
(2−テトラヒドロフリル)−5−フルオロウラクルの
分解を何ら引き起こすことなく、副生(2−テトラヒド
ロフリル) −5−フルオロウラシルへ導くことを見い
出し、本発明を児成した。
The inventors of the present invention took into account the above-mentioned problems and conducted intensive research to find an industrially simple and inexpensive manufacturing method. In the reaction, by coexisting a carboxylic acid in a pyridine solvent, the reaction efficiency is increased compared to when it is not present (see comparative example), and furthermore, the reaction solvent obtained can be carried out without distilling off the solvent. The 1-
It was discovered that the by-product (2-tetrahydrofuryl)-5-fluorouracil can be produced without causing any decomposition of (2-tetrahydrofuryl)-5-fluorouracil, and the present invention was created.

〔発明の概要〕 本発明は、ピリジン中カルボン醪の存在下、5−フルオ
ロウラクルと2.3−)とドロフランを反応させた後、
得られた反応溶液へカルボン#塩の水溶液を加えて処理
することを特を改とするものであり、本発明により、高
純度の1−(−一テトラヒドロフリル)−5−フルオロ
ウラクルヲ簡儒で安価に、しかも高収率及び高純ルニで
製〕Aすることができる。
[Summary of the Invention] The present invention involves reacting 5-fluorouracul with 2.3-) and dolofuran in the presence of carvone mash in pyridine, and then
The special modification is to add an aqueous solution of carvone #salt to the obtained reaction solution for treatment.According to the present invention, highly pure 1-(-1-tetrahydrofuryl)-5-fluorourachlor can be easily prepared. [A] can be produced at low cost, in high yield, and with high purity.

2.3−′)ヒトミツ2ンの使用1は5−フルオロウラ
シルに対して、1,10倍モルでるるか、反応の効率及
び経済性の観点から1〜4倍モルが好ましいう 前記反応はピリジン中、カルボンmの存在下に行うこと
が心安でるる。カルボン6!としては、ギ酸、酢酸、プ
ロピオン酸、酪酸、吉草酸、カプロン酸、カプリル酸、
ゾーウr春、コ・・り酸、安息香酸等を例示することが
できるが、経済性及び反応後の分汎の硯点から炭素数4
個以下の低級脂肪族カルボン酸が好ましい。カルボン酸
の使用量1ま5−フルオロウラクルに対して0.1倍モ
ルから2.5倍モルを選ぶことができる。0.1倍モル
より少ない場合及び2.5倍モルよシ多い場合は添加し
た効果は小さい。5−フルオロウラクルと2.3−9ヒ
ドロフランとのri応湿温度80℃〜18Ll″Cで進
行するが反応効率及び生成物の純度を上げるためには1
00’Q、160°Cが好ましい。
2.3-') Use of pyridine 1 is 1.10 times the molar amount of 5-fluorouracil, or preferably 1 to 4 times the molar amount from the viewpoint of reaction efficiency and economical efficiency. Of course, it is safe to do this in the presence of carvone m. Carbon 6! Examples include formic acid, acetic acid, propionic acid, butyric acid, valeric acid, caproic acid, caprylic acid,
Examples include chlorine, co-phosphoric acid, benzoic acid, etc., but from the viewpoint of economy and the inkstone point of division after reaction, carbon atoms with 4 carbon atoms are used.
or less lower aliphatic carboxylic acids are preferred. The amount of carboxylic acid to be used can be selected from 0.1 to 2.5 moles per 1 to 5-fluorouracul. The effect of addition is small when it is less than 0.1 times the mole and when it is more than 2.5 times the mole. The reaction between 5-fluorouracul and 2.3-9 hydrofuran proceeds at a humidity temperature of 80°C to 18Ll″C, but in order to increase the reaction efficiency and the purity of the product,
00'Q, 160°C is preferred.

本発明は前記反応により得られた反応溶液をカルボン酸
塩の水溶液で処理することを必須の要件とする。カルボ
ン酸塩としては、酢酸ナトリウム、酢酸カリウム、酢酸
リチウム、酢酸マグネシウム、酢酸カルシウム、グロピ
オン酸ナトリウム、ギ酸ナトリウム、ギ酸カリウム、/
エラ酸ナトリウム、コハク酸す) IJクム、酢酸鋼、
酢酸亜鉛、酪酸ナトリウム、吉草酸ナトリウム、カプリ
ル酸ナトリウム、カプリン酸ナトリウム、ステアリン酸
ナトリウム、安息香酸ナトリウム等を例示することがで
きるが経済性の点から炭素数8個以下から成るカルボン
酸アルカリ金X*又はアルカリ土類金属塩が好ましい。
The present invention requires that the reaction solution obtained by the above reaction be treated with an aqueous solution of a carboxylate salt. Carboxylate salts include sodium acetate, potassium acetate, lithium acetate, magnesium acetate, calcium acetate, sodium glopionate, sodium formate, potassium formate, /
sodium ellaate, succinic acid) IJ cum, acetic acid steel,
Examples include zinc acetate, sodium butyrate, sodium valerate, sodium caprylate, sodium caprate, sodium stearate, sodium benzoate, etc., but from the viewpoint of economy, alkali metal carboxylates having 8 or less carbon atoms *Or alkaline earth metal salts are preferred.

カルボン酸塩の水溶液の濃度は0.01モル濃度〜10
モル濃度の範囲で選ぶことができるが、反応の選択性、
効−6性、及び経済性から0,05〜5モルイ漣度が好
ましい。カルボン酸塩の水溶液による処理温度d家電か
ら100’Oの          [範囲であるが反
応の効率の点から40C〜90゛Cが好ましい。なおり
ルボン酸塩の水e+4 tiによる処理において本反応
の利点をそこなわない範囲で他の溶媒、たとえばメタノ
ール、エタノール等を用いても何ら支障はない。なお、
カルボン酸とカルボン酸塩の酸根は同一であっても異な
ってもよい。
The concentration of the aqueous solution of carboxylate is 0.01 molar to 10
It can be selected within a range of molar concentration, but the selectivity of the reaction,
From the viewpoint of effectiveness and economy, a molar ratio of 0.05 to 5 is preferred. Treatment temperature with an aqueous solution of carboxylic acid salt d ranges from household appliances to 100°C, but from the viewpoint of reaction efficiency, 40°C to 90°C is preferable. In the treatment of the rubonate salt with water e+4 ti, there is no problem in using other solvents such as methanol, ethanol, etc., as long as the advantages of this reaction are not impaired. In addition,
The acid groups of the carboxylic acid and the carboxylate may be the same or different.

またカルボン酸塩の効果は、1.3−ビス(2−テトラ
ヒドロフリル)−5−フルオロウラクルの1−(2−テ
トラヒドロフリル)−5−フルオロウラシルへの選択的
な変換ばかりでなく、反応後生酸物は水層より有機溶媒
(たとえばクロロホルム)により抽出されるのであるが
、カルボン酸塩はその際の塩析効果もかねることができ
るので抽出操作の効率を高めるという、さらなる利点が
6る0 本発明を実施例及び比較例によりさらに一細に説明する
In addition, the effect of carboxylate is not only the selective conversion of 1,3-bis(2-tetrahydrofuryl)-5-fluorouracil to 1-(2-tetrahydrofuryl)-5-fluorouracil, but also the effect of Acids are extracted from the aqueous layer with organic solvents (for example, chloroform), and carboxylic acid salts can also act as a salting-out effect during this process, so they have the additional advantage of increasing the efficiency of the extraction operation. The present invention will be explained in more detail with reference to Examples and Comparative Examples.

実施1711 10m3応管淋;=ブ3に5−フルオロウラシル0.2
5g(1,92mmol)、ピリジン2.5猷、酢酸5
81v(0,97mmo 1 )及び2,3−ンヒドロ
フラ10.27 g (3,8mmo l )を脱気条
件下封管し、1)0 ’(IX″ml、′ で24時間加熱した。放冷後、反応液に1.0m//酢
酸ナトリウム水溶a2.5mlを加え、70℃で4.5
時間攪拌した。反応液を減圧下に、N去した後水とりa
ロホルムを加えて輌とうじ分液した。クロロホルム層を
硫虐マグネシウムで乾燥させたLをクロロホルムを留去
することによって0.347 gの1−(2−テトラヒ
ドロフリル)−5−フルオロウラクルを結晶として得た
。収率は90チでめった。薄層クロマドグ7フイーによ
って分析したところ単一スポットでありだ。
Implementation 1711 10m3 5-fluorouracil 0.2 to 3
5g (1.92mmol), 2.5g of pyridine, 5g of acetic acid
81v (0.97 mmol) and 10.27 g (3.8 mmol) of 2,3-one hydrofuran were sealed in a tube under deaerated conditions, and heated at 1) 0'(IX''ml,' for 24 hours. Allowed to cool. After that, 2.5 ml of 1.0 m//aqueous sodium acetate solution was added to the reaction solution, and the mixture was heated to 4.5 ml at 70°C.
Stir for hours. After removing N from the reaction solution under reduced pressure, take water a.
Roform was added and the liquids were separated. The chloroform layer was dried over magnesium sulfate and the chloroform was distilled off to obtain 0.347 g of 1-(2-tetrahydrofuryl)-5-fluorouracul as crystals. The yield was 90 cm. When analyzed using a thin-layer Chromadog 7F, it was found to be a single spot.

尚、得られた結晶を一部エタノールより再結晶\しl 牛#批たものの融点及び元素分析値を次に不しだ。In addition, some of the obtained crystals were recrystallized from ethanol. The melting point and elemental analysis values of the beef were as follows.

融点 164−168’C(文献値165−1690薬
業時報社) 元素分析 計算値 C:48.00.H:4.53.N:14,0
0%。
Melting point 164-168'C (literature value 165-1690 Yakugyo Jihosha) Elemental analysis calculated value C: 48.00. H:4.53. N:14,0
0%.

実迎11直  C:47.72.H:4.56.N:1
3.84%。
Actual pick-up 11th shift C: 47.72. H:4.56. N:1
3.84%.

実施例2〜8 表1には種々の条件下で行なった結果を示す。Examples 2-8 Table 1 shows the results conducted under various conditions.

記載されていない条件は実施例1と同様に行ない後処理
をした。なお宍1には実施例1も含わせて示し友。
Post-treatment was performed under the same conditions as in Example 1 except for conditions not listed. In addition, Example 1 is also included in Figure 1.

比較例 5−7 ルオa +7 ラシル0.25g(1,92m
mol)、ピリ2/2.5m、及び2.3−ンヒドロフ
ラン0.27g (3,8mmoりの混合液に酢酸11
59(1,92mmoりを加えたものと酢酸を加えない
ものの反応液を1℃〜の反応管琳;=#事に脱気条件下
封管し、110℃で24時間加熱し九。その反応液を分
析したところ5−フルオロラフシルの反応率は酢酸を加
えたものは82%であるのに比べ、酢酸を加えなかった
ものは50係でめった。
Comparative Example 5-7 Luo a +7 Rasil 0.25g (1,92m
acetic acid 11 to a mixture of 0.27 g (3.8 mmol), pyri2/2.5m, and 2.3-enhydrofuran
59 (1.92 mmol) and the reaction solution without acetic acid were sealed in a reaction tube at 1°C or higher under deaerated conditions and heated at 110°C for 24 hours.9.The reaction. When the liquid was analyzed, the reaction rate of 5-fluororafcyl was 82% in the case where acetic acid was added, whereas it was 50% in the case where acetic acid was not added.

Claims (6)

【特許請求の範囲】[Claims] (1)カルボン酸の存在下、ピリジン中、5−フルオロ
ウラシルと2,3−ジヒドロフランとを反応させた後、
得られる反応溶液にカルボン酸塩の水溶液を加えて処理
することを特徴とする、1−(2−テトラヒドロフリル
)−5−フルオロウラシルの製造方法。
(1) After reacting 5-fluorouracil and 2,3-dihydrofuran in pyridine in the presence of a carboxylic acid,
A method for producing 1-(2-tetrahydrofuryl)-5-fluorouracil, which comprises adding an aqueous solution of a carboxylic acid salt to the resulting reaction solution.
(2)カルボン酸の存在下、ピリジン中、80℃〜18
0℃で5−フルオロウラシルと2,3−ジヒドロフラン
とを反応させた後、得られる反応溶液にカルボン酸塩の
水溶液を加えて室温〜 100℃で処理することを特徴とする、特許請求の範囲
第(1)項に記載の方法。
(2) In the presence of carboxylic acid, in pyridine, from 80°C to 18°C
Claims characterized in that after 5-fluorouracil and 2,3-dihydrofuran are reacted at 0°C, an aqueous solution of a carboxylic acid salt is added to the resulting reaction solution and treated at room temperature to 100°C. The method described in paragraph (1).
(3)カルボン酸が低級脂肪族カルボン酸である、特許
請求の範囲第(1)又は(2)項に記載の方法。
(3) The method according to claim (1) or (2), wherein the carboxylic acid is a lower aliphatic carboxylic acid.
(4)カルボン酸の使用量が5−フルオロウラシルに対
し、0.1倍モルから2.5倍モルである、特許請求の
範囲第(1)、(2)又は(3)項に記載の方法。
(4) The method according to claim (1), (2) or (3), wherein the amount of carboxylic acid used is 0.1 to 2.5 times by mole relative to 5-fluorouracil. .
(5)カルボン酸塩が炭素数8個以下からなるカルボン
酸アルカリ金属塩又はアルカリ土類金属塩である、特許
請求の範囲第(1)、(2)、(3)又は(4)項に記
載の方法。
(5) Claims No. (1), (2), (3), or (4), wherein the carboxylic acid salt is an alkali metal salt or alkaline earth metal salt of a carboxylic acid having 8 or less carbon atoms. Method described.
(6)カルボン酸塩の水溶液の濃度が0.01〜10モ
ル濃度である、特許請求の範囲第(1)、(2)、(3
)、(4)又は(5)項に記載の方法。
(6) Claims (1), (2), and (3) wherein the concentration of the aqueous solution of the carboxylate is 0.01 to 10 molar.
), (4) or (5).
JP59232498A 1984-11-06 1984-11-06 Production of 1-(2-tetrahydrofuryl)-5-fluorouracil Granted JPS61112073A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP59232498A JPS61112073A (en) 1984-11-06 1984-11-06 Production of 1-(2-tetrahydrofuryl)-5-fluorouracil
KR1019850008257A KR920006418B1 (en) 1984-11-06 1985-11-05 Process for the preparation of 1-(2-tetrahydrofuryl)-s-fluorouracil
CN85108855A CN1014893B (en) 1984-11-06 1985-11-06 Process for producing 1-(2-tetrahydrofuryl)-5-flurouracil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59232498A JPS61112073A (en) 1984-11-06 1984-11-06 Production of 1-(2-tetrahydrofuryl)-5-fluorouracil

Publications (2)

Publication Number Publication Date
JPS61112073A true JPS61112073A (en) 1986-05-30
JPH0430956B2 JPH0430956B2 (en) 1992-05-25

Family

ID=16940264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59232498A Granted JPS61112073A (en) 1984-11-06 1984-11-06 Production of 1-(2-tetrahydrofuryl)-5-fluorouracil

Country Status (3)

Country Link
JP (1) JPS61112073A (en)
KR (1) KR920006418B1 (en)
CN (1) CN1014893B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004102508A (en) * 2002-09-06 2004-04-02 Renesas Technology Corp Semiconductor storage device
CN102285972A (en) * 2011-08-08 2011-12-21 江苏大学 Process for preparing tegafur
CN107235967B (en) * 2017-07-27 2019-10-15 福州大学 The synthesis technology of anti-tumor drug Tegafur

Also Published As

Publication number Publication date
KR860004054A (en) 1986-06-16
CN1014893B (en) 1991-11-27
CN85108855A (en) 1986-09-24
JPH0430956B2 (en) 1992-05-25
KR920006418B1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
EP0297647B1 (en) Process for the production of alkylene carbonate
JPS61112073A (en) Production of 1-(2-tetrahydrofuryl)-5-fluorouracil
US4578222A (en) Process for preparing a perfluorinated or polyfluorinated aliphatic carboxylic acid
CA1197254A (en) Process for the carbonylization of secondary benzyl halids
US4048236A (en) Process for preparing o-alkoxy-p-allylphenols
JPS6241655B2 (en)
EP0844239B1 (en) Method for producing homocystine
US4384118A (en) 4-(3-Iodopropargyloxy) pyrimidine derivatives
JP2678784B2 (en) Method for producing adamantane triols
JPH06306037A (en) Production of 1,4-dicyano-2-butene
JPS6340424B2 (en)
JPS6316375B2 (en)
JP2001187778A (en) METHOD FOR PRODUCING beta-MERCAPTOPROPIONIC ACID
KR100401284B1 (en) Method for preparing 1-bromoethyl acetate
US6313342B1 (en) Synthesis of esters of mercaptocarboxylic acids
EP0138436A2 (en) Process for producing ketals of 2-Ketogulonic acid or its esters
JP2943318B2 (en) Method for producing aliphatic dicarboxylic acid monoester
JP3278945B2 (en) Method for producing parafluorophenol
EP0330203B1 (en) Catalytic process for preparing ethylene-tetracarboxylic esters
JP5000031B2 (en) Method for producing aromatic-o-dialdehyde compound
JPS58134061A (en) Production of glycine metal complex
JPS62132849A (en) Production of d-or l-n-t-butoxycarbonyl-o-benzylserine
US4450293A (en) Preparation of α-hydroxyisobutyric acid using a thallic halide catalyst
JPS6155507B2 (en)
JPS6318941B2 (en)